Antidepressant fluvoxamine reduces cerebral infarct volume and ameliorates sensorimotor dysfunction in experimental stroke

NeuroReport

Volumn 25, Issue 10, 2014, Pages 731-736

  Sato, Shinsuke ^a   Kawamata, Takakazu ^a   Kobayashi, Tomonori ^a   Okada, Yoshikazu ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cerebral infarction; Fluvoxamine; Middle cerebral artery occlusion model; Sensorimotor function; Sigma 1 receptor

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; FLUVOXAMINE; ANTIDEPRESSANT AGENT; NEUROPROTECTIVE AGENT; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CHRONOTHERAPY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; EXPERIMENTAL STROKE; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR NEUROPATHY; AGONISTS; ANIMAL; CEREBRAL INFARCTION; COMPLICATION; PSYCHOMOTOR DISORDERS; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CEREBRAL INFARCTION; FLUVOXAMINE; MALE; NEUROPROTECTIVE AGENTS; PSYCHOMOTOR DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA;

EID: 84902546420     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000162     Document Type: Article

References (22)

1. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 1996; 93:8072-8077. (Pubitemid 26277167)
2. Hayashi T, Su TP. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc Natl Acad Sci USA 2004; 101:14949-14954. (Pubitemid 39410779)
3. Meyer DA, Carta M, Partridge LD, Covey DF, Valenzuela CF. Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic sigma1-like receptors. J Biol Chem 2002; 277:28725-28732.
4. Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 2007; 131:596-610. (Pubitemid 350017760)
5. Takebayashi M, Hayashi T, Su TP. A perspective on the new mechanism of antidepressants: Neuritogenesis through sigma-1 receptors. Pharmacopsychiatry 2004; 37:S208-S213. (Pubitemid 39578130)
6. Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G. Neuroprotective effects of sigma-1 receptor agonists against beta-Amyloidinduced toxicity. Neuroreport 2005; 16:1223-1226. (Pubitemid 41058473)
7. Maurice T. Cognitive effects of sigma-receptor ligands. In: Matsumoto RR, Bowen WD, Su TP, editors. Sigma receptors: Chemistry, cell biology and clinical implications. New York: Springer Chapter 12; 2007. pp. 237-271.
8. Ajmo CT Jr, Vernon DO, Collier L, Pennypacker KR, Cuevas J. Sigma receptor activation reduces infarct size at 24 h after permanent middle cerebral artery occlusion in rats. Curr Neurovasc Res 2006; 3:89-98. (Pubitemid 43778702)
9. Narita N, Hashimoto K, Tomitaka S, Minabe Y. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol 1996; 307:117-119. (Pubitemid 26226293)
10. Lesage AS, De Loore KL, Peeters L, Leysen JE. Neuroprotective sigma ligands interfere with the glutamate-Activated NOS pathway in hippocampal cell culture. Synapse 1995; 20:156-164.
11. Lobner D, Lipton P. Sigma-ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia. Neurosci Lett 1990; 117:169-174. (Pubitemid 20284094)
12. Kobayashi T, Kawamata T, Mitsuyama T, Hori T. Modified permanent middle cerebral artery occlusion rat model aiming to reduce variability in infarct size. Neurol Res 2007; 29:884-887. (Pubitemid 350255165)
13. Kobayashi T, Kawamata T, Shibata N, Okada Y, Kobayashi M, Hori T. Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A2 level in experimental stroke. J Neurotrauma 2009; 26:2355-2364.
14. De Ryck M, Van Reempts J, Duytschaever H, Van Deuren B, Clincke G. Neocortical localization of tactile/proprioceptive limb placing reactions in the rat. Brain Res 1992; 573:44-60.
15. Kawamata T, Alexis NE, Dietrich WD, Finklestein SP. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 1996; 16:542-547. (Pubitemid 26227062)
16. Kawamata T, Dietrich WD, Schallert T, Gotts JE, Cocke RR, Benowitz LI, et al. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci USA 1997; 94:8179-8184. (Pubitemid 27343797)
17. Kawamata T, Ren J, Chan TC, Charette M, Finklestein SP. Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. Neuroreport 1998; 9:1441-1445. (Pubitemid 28264266)
18. Mitsuyama T, Kawamata T, Yamane F, Awaya A, Hori T. Role of a synthetic pyrimidine compound, MS-818, in reduction of infarct size and amelioration of sensorimotor dysfunction following permanent focal cerebral ischemia in rats. J Neurosurg 2002; 96:1072-1076. (Pubitemid 34579025)
19. Yang S, Bhardwaj A, Cheng J, Alkayed NJ, Hurn PD, Kirsch Jr. Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2. Anesth Analg 2007; 104:1179-1184. (Pubitemid 46649941)
20. Shen YC, Wang YH, Chou YC, Liou KT, Yen JC, Wang WY, et al. Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation. J Neurochem 2008; 104:558-572.
21. Li Z, Zhou R, Cui S, Xie G, CaiW, Sokabe M, et al. Dehydroepiandrosterone sulfate prevents ischemia-induced impairment of long-Term potentiation in rat hippocampal CA1 by up-regulating tyrosine phosphorylation of NMDA receptor. Neuropharmacology 2006; 51:958-966. (Pubitemid 44528605)
22. Berridge MJ, Bootman MD, Lipp P. Calcium: A life and death signal. Nature 1998; 395:645-648.